BofA Securities on Eli Lilly (LLY): 'a particularly good buying opportunity'

Go back to BofA Securities on Eli Lilly (LLY): 'a particularly good buying opportunity'

Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance

January 14, 2025 9:00 AM EST

2024 revenue is expected to be approximately $45.0 billion for the full year, $4.0 billion above the midpoint of first-time 2024 financial guidance

Q4 2024 revenue is expected to be approximately $13.5 billion, approximately $400 million below the low end of recently issued financial guidance

The company anticipates 2025 revenue to be in the range of $58.0 billion to $61.0 billion, growth of 32% at the midpoint compared to expected 2024... More